Prospective, Observational, Real-world Oral Malignant Tumors Study
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 1000
Summary
- Conditions
- Head and Neck Neoplasms
- Postoperative Complications
- Quality of Life
- Design
- Observational Model: OtherTime Perspective: Prospective
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
A register system of oral and maxillofacial malignant tumors based on a prospective, observational, real-world study in north Chinese population was absent. The aim of the study is to construct a register system of oral and maxillofacial malignant tumors based on a prospective, observational, real-w...
A register system of oral and maxillofacial malignant tumors based on a prospective, observational, real-world study in north Chinese population was absent. The aim of the study is to construct a register system of oral and maxillofacial malignant tumors based on a prospective, observational, real-world study in Chinese population. The variables in the study include social informatics, etiology, and psychological and quality of life, coexistence disease, baseline clinicopathological data, postoperative complications, and long-term follow-up results. By released annual analysis report, the epidemiological features and prognostic factors of oral and maxillofacial malignant tumors in north Chinese population can be identified.
Tracking Information
- NCT #
- NCT02395367
- Collaborators
- Peking University Hospital of Stomatology
- Beijing Shijitan Hospital of Capital Medical University
- Beijing Friendship Hospital
- Investigators
- Principal Investigator: Zhien Feng, M.D., Ph.D. Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University. Principal Investigator: Dian-can Wang, M.D. Department of Oral and Maxillofacial Surgery, School of Stomatology Peking University. Principal Investigator: Xiaolei Liu, Ph.D. Department of Radiation Oncology, Beijing Shijitan Hospital, Capital Medical University Principal Investigator: Zhen Wang, Ph.D. Beijing Friendship Hospital, Capital Medical Universiy